

Enter your email to stay informed about occasional coupons and promotions. We only send emails when there’s something worth sharing.
The weight loss industry has undergone a massive transformation with the rise of GLP-1 receptor agonists and next-generation incretin-based therapies. What was once a slow, frustrating process is now being revolutionized by compounds capable of producing 15–30% total body weight loss—numbers previously only achievable with bariatric surgery.
At the forefront of this revolution are drugs like Tirzepatide, Semaglutide, and emerging powerhouses like Retatrutide and CagriSema.
This guide breaks down every major GLP-based compound, ranks them based on real-world effectiveness, and shows you what’s coming next—so you can stay ahead of the curve.
Before ranking the drugs, you need to understand how they work.
👉 The more pathways activated, the more powerful the fat loss effect.
Retatrutide is the first compound to fully combine appetite suppression AND metabolic acceleration.
Unlike older drugs that only make you eat less, this one also makes your body burn more fat at rest.
👉 Verdict: Future #1 drug in the world
Tirzepatide combines appetite suppression with improved metabolic signaling, making it significantly more effective than semaglutide.
👉 Verdict: Best option available TODAY
This stack targets satiety signaling from multiple angles, making hunger almost disappear.
👉 Verdict: Likely top 3 globally
This drug excels in reducing liver fat, making it ideal for metabolic disease patients.
👉 Verdict: Best niche metabolic drug
This drug excels in reducing liver fat, making it ideal for metabolic disease patients.
| Rank | Drug | Mechanism | Weight Loss | Category |
|---|---|---|---|---|
| 🥇 #1 | Retatrutide | GLP-1 + GIP + Glucagon | 24–30% | Elite |
| 🥈 #2 | Tirzepatide | GLP-1 + GIP | 15–25% | Gold Standard |
| 🥉 #3 | CagriSema | GLP-1 + Amylin | 20–25% | High Potency |
| 🏅 #4 | Survodutide | GLP-1 + Glucagon | High | Metabolic |
| 🏅 #5 | Semaglutide | GLP-1 | 10–15% | Proven |
| 🏅 #6 | Mazdutide | GLP-1 + Glucagon | Moderate | Emerging |
| 🏅 #7 | Liraglutide | GLP-1 | 5–8% | Legacy |
👉 Tirzepatide (now) → Retatrutide (future)
👉 CagriSema
👉 Survodutide
Retatrutide
Yes — significantly more effective
Tirzepatide → Retatrutide
WhatsApp us